The high road to ‘high tech’ and its impact on life science hires- Hays careers advice

The high road to ‘high tech’ and its impact on life science hires

We’ve talked a lot about the increasing impact of medical technology (med tech) on the life science hiring space (for notable trends, check out this post). But medical technology is rapidly giving way to what could be called the ‘high tech’ categories of the industry – namely robotics, sensing and virtual reality.

These areas are accounting for more and more med tech funding and hiring; companies recruiting the largest numbers of new employees are increasingly those with a technical focus.

This brave new world offers solutions to life’s health care conundrums that, as little as ten years ago, would have been undreamt of by most of us. As diagnostics are miniaturised into wrist-watches and robots replace doctors in performing surgery, medicine and the network of jobs that surround it, is becoming unrecognisable.

Google and medical interests unite

Google has recently partnered with medical manufacturing companies and health authorities in a number of high-profile collaborations:

  • Verily (formerly Google Life Sciences) has joined Dexcom to produce a subcutaneous continuous glucose monitor ‘patch’ for people with Type 2 diabetes. Using miniature sensors, this piece of high tech kit will detect and feed an individual’s blood glucose data to a centralised database, using wireless connectivity for tracking and monitoring.
  • Google Deepmind has been working with the National Health Service (NHS) in London, to systematise early detection of common and debilitating eye diseases such as macular degeneration. The company’s British-based artificial intelligence division is using machine learning to analyse more than one million eye scans, creating algorithms that can detect early warning signs that might be missed by human doctors.
  • Google’s Verily is also working with Johnson & Johnson on a joint surgical robotics venture, Verb Surgical, to create a digital surgery platform which combines robotics, advanced visualisation, data analytics and wireless connectivity. This new way of performing surgery, it claims, will achieve improved patient outcomes, lower costs and greater hospital efficiency.

The emergence of high-tech medical startups

While Google is at the forefront of this ‘technification’ of medicine, venture capital and government money pour into seeding startups with a health IT or high tech medical focus. This kind of funding interest is fuelling hiring and expansion.

Such fledgeling companies are recruiting highly experienced executives from larger industry sources to help them build operations and commercialise. Candidates with corporate experience and the energy to work at the heady pace of a startup are increasingly in demand.

High tech and the work environment

Tech’s growing dominance in the health care arena may be gradually ushering in the ‘Google-isation’ of office spaces, with conventional settings being replaced by ‘uber-trendy’ work and play stations. Some professionals participating in the US Medical Device and Diagnostics Industry Medtech Salary Survey 2016 reported flexible working hours, on-site gymnasiums and childcare, subsidised meals and modernised workplaces as benefits to working in this emerging sector. More than two-thirds of full-time med tech employees also said they had received a bonus in the last 12 months, with the median at $USD10,000.

I hope you have found the above interesting. You may find the below blogs of use:

Stay up to date with latest news from across the globe by joining our LinkedIn group, Life Sciences Industry Insights with Hays and follow us on Twitter @HaysLS 


Paul Strouts is the Global Managing Director for Hays Life Sciences, looking after 27 countries within the group’s portfolio, spanning from New York in the US to Sydney in Australia. From his base in our flagship London office, Paul oversees all operations and sales for the brand, and drives the business forward on a strategic level.

He joined Hays in 2007 following the acquisition of his Life Sciences business (James Harvard International) and has been involved in the sector since 2001, after becoming interested in Life Sciences whilst living near Harvard in Boston, MA. Paul is a graduate of the London Metropolitan University, and resides in the Home Counties, UK.